NCT06730347Phase 2Recruiting

A Study of Lorigerlimab in Participants With Advanced Solid Tumors

Study sponsor: MacroGenics

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-07Estimated
Enrollment · participants80Estimated
Source updated2026-06-02Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 2 fields changed

Planned enrollment increased by 20 participants

Before: 60 participants (planned). After: 80 participants (planned).

Primary completion date changed

Before: Feb 2027. After: Jul 2027.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview